Comparison Chart BerGenBio ASA

Equities

Real-time Oslo Bors Other stock markets 06:44:15 2024-05-21 am EDT			5-day change	1st Jan Change
0.1338 ^NOK	+2.45%		+9.49%	-51.87%

Mar. 20	Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation	CI
Feb. 14	BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BERGENBIO ASA	Bio Therapeutic Drugs	+2.45%	+9.49%	-51.87%	-88.85%	-99.40%	47.77M